SBC SBC MED GROUP HLDGS INC revenue, earnings and financials
For the quarter ended June 30, 2026, SBC MED GROUP HLDGS INC reported revenue of $49.2M (up 13.4% from a year earlier), net income of $10.7M and diluted EPS of $0.10; over the last four quarters revenue was $175M and net income $49.0M; for the fiscal year ended December 2025 revenue was $174M, down 15.5% on the year before.
SBC annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $174M, gross profit $127M, operating income $67.5M, net income $51.0M (margin 29.4%), EPS $0.50
- Fiscal year ended Dec 2024: revenue $205M, gross profit $156M, operating income $70.3M, net income $46.6M (margin 22.7%), EPS $0.48
- Fiscal year ended Dec 2023: revenue $194M, gross profit $137M, operating income $70.7M, net income $39.4M (margin 20.3%), EPS $0.42
SBC quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $49.2M (up 13.4% year over year), net income $10.7M, EPS $0.10
- Quarter ended Mar 31, 2026: revenue $43.1M (down 9.0% year over year), net income $11.3M, EPS $0.11
- Quarter ended Dec 31, 2025 (from the annual report): revenue $39.6M (down 10.9% year over year), net income $14.2M, EPS $0.15
- Quarter ended Sep 30, 2025: revenue $43.4M (down 18.3% year over year), net income $12.8M, EPS $0.12
- Quarter ended Jun 30, 2025: revenue $43.4M (down 18.3% year over year), net income $2.46M, EPS $0.02
- Quarter ended Mar 31, 2025: revenue $47.3M (down 13.6% year over year), net income $21.5M, EPS $0.21
- Quarter ended Dec 31, 2024 (from the annual report): revenue $44.4M, net income $6.54M, EPS $0.05
- Quarter ended Sep 30, 2024: revenue $53.1M (up 12.3% year over year), net income $2.83M, EPS $0.03
- Quarter ended Jun 30, 2024: revenue $53.1M, net income $18.5M, EPS $0.20
- Quarter ended Mar 31, 2024: revenue $54.8M, net income $18.8M, EPS $0.20
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income $30.2M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $47.3M, net income $8.36M, EPS $0.09
- Quarter ended Jun 30, 2023: revenue n/a, net income $197K, EPS n/a
- Quarter ended Mar 31, 2023: revenue n/a, net income $613K, EPS n/a
- Quarter ended Sep 30, 2022: revenue n/a, net income −$11.4K, EPS n/a
- Quarter ended Jun 30, 2022: revenue n/a, net income −$1.28K, EPS n/a
SBC cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $24.7M, share buybacks $5.00M
- Fiscal year ended Dec 2024: operating cash flow $20.6M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $50.7M, share buybacks n/a
SBC balance sheet
- Jun 30, 2026: cash $184M, total assets $407M, total liabilities $127M, shareholders' equity $264M
- Mar 31, 2026: cash $167M, total assets $388M, total liabilities $118M, shareholders' equity $255M
- Dec 31, 2025: cash $164M, total assets $380M, total liabilities $117M, shareholders' equity $248M
- Sep 30, 2025: cash $127M, total assets $321M, total liabilities $73.3M, shareholders' equity $248M
- Jun 30, 2025: cash $153M, total assets $315M, total liabilities $70.6M, shareholders' equity $245M
- Mar 31, 2025: cash $132M, total assets $285M, total liabilities $58.3M, shareholders' equity $226M
- Dec 31, 2024: cash $125M, total assets $266M, total liabilities $71.1M, shareholders' equity $195M
- Sep 30, 2024: cash $137M, total assets $296M, total liabilities $91.0M, shareholders' equity $205M
What is SBC's revenue?
SBC MED GROUP HLDGS INC reported $175M of revenue over its last four quarters, through June 30, 2026.
Is SBC profitable?
Yes. SBC MED GROUP HLDGS INC earned $49.0M over the last four quarters.
What is SBC's EPS?
Diluted earnings per share over the last four quarters were $0.48; $0.10 in the latest quarter.